127 related articles for article (PubMed ID: 12820722)
21. Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells.
Pinho S; Marcos NT; Ferreira B; Carvalho AS; Oliveira MJ; Santos-Silva F; Harduin-Lepers A; Reis CA
Cancer Lett; 2007 May; 249(2):157-70. PubMed ID: 16965854
[TBL] [Abstract][Full Text] [Related]
22. Curcumin-mediated transcriptional regulation of human
An SY; Kim KS; Cho JH; Kim HD; Kim CH; Lee YC
Front Mol Biosci; 2022; 9():985648. PubMed ID: 36172045
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic Regulation of Glycosylation in Cancer and Other Diseases.
Indellicato R; Trinchera M
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804149
[TBL] [Abstract][Full Text] [Related]
24. Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness.
Cotton S; Ferreira D; Soares J; Peixoto A; Relvas-Santos M; Azevedo R; Piairo P; Diéguez L; Palmeira C; Lima L; Silva AMN; Lara Santos L; Ferreira JA
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562270
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Cosmc suppresses cell migration and invasion in different subtypes of breast cancer cells via Tn and T glycans.
Liu J; Xu F; Li J; Jiang H
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32452513
[TBL] [Abstract][Full Text] [Related]
26. Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers.
Loureiro LR; Feldmann A; Bergmann R; Koristka S; Berndt N; Máthé D; Hegedüs N; Szigeti K; Videira PA; Bachmann M; Arndt C
J Exp Clin Cancer Res; 2020 May; 39(1):77. PubMed ID: 32370811
[TBL] [Abstract][Full Text] [Related]
27. A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis.
Gupta R; Leon F; Rauth S; Batra SK; Ponnusamy MP
Cells; 2020 Feb; 9(2):. PubMed ID: 32075174
[TBL] [Abstract][Full Text] [Related]
28. Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids.
Loureiro LR; Sousa DP; Ferreira D; Chai W; Lima L; Pereira C; Lopes CB; Correia VG; Silva LM; Li C; Santos LL; Ferreira JA; Barbas A; Palma AS; Novo C; Videira PA
Sci Rep; 2018 Aug; 8(1):12196. PubMed ID: 30111774
[TBL] [Abstract][Full Text] [Related]
29. Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities.
Rodrigues E; Macauley MS
Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29912148
[TBL] [Abstract][Full Text] [Related]
30. Tn and STn are members of a family of carbohydrate tumor antigens that possess carbohydrate-carbohydrate interactions.
Sletmoen M; Gerken TA; Stokke BT; Burchell J; Brewer CF
Glycobiology; 2018 Jul; 28(7):437-442. PubMed ID: 29618060
[TBL] [Abstract][Full Text] [Related]
31. Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to
Severino PF; Silva M; Carrascal M; Malagolini N; Chiricolo M; Venturi G; Astolfi A; Catera M; Videira PA; Dall'Olio F
Oncotarget; 2017 Aug; 8(33):54506-54517. PubMed ID: 28903359
[TBL] [Abstract][Full Text] [Related]
32. Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells.
Kwon KM; Chung TW; Kwak CH; Choi HJ; Kim KW; Ha SH; Cho SH; Lee YC; Ha KT; Lee MJ; Kim CH
Int J Biol Sci; 2017; 13(3):265-275. PubMed ID: 28367091
[TBL] [Abstract][Full Text] [Related]
33. Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity.
Prendergast JM; Galvao da Silva AP; Eavarone DA; Ghaderi D; Zhang M; Brady D; Wicks J; DeSander J; Behrens J; Rueda BR
MAbs; 2017; 9(4):615-627. PubMed ID: 28281872
[TBL] [Abstract][Full Text] [Related]
34. Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions.
Haugstad KE; Hadjialirezaei S; Stokke BT; Brewer CF; Gerken TA; Burchell J; Picco G; Sletmoen M
Glycobiology; 2016 Dec; 26(12):1338-1350. PubMed ID: 27282157
[TBL] [Abstract][Full Text] [Related]
35. The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer.
Munkley J; Oltean S; Vodák D; Wilson BT; Livermore KE; Zhou Y; Star E; Floros VI; Johannessen B; Knight B; McCullagh P; McGrath J; Crundwell M; Skotheim RI; Robson CN; Leung HY; Harries LW; Rajan P; Mills IG; Elliott DJ
Oncotarget; 2015 Oct; 6(33):34358-74. PubMed ID: 26452038
[TBL] [Abstract][Full Text] [Related]
36. Challenges in Antibody Development against Tn and Sialyl-Tn Antigens.
Loureiro LR; Carrascal MA; Barbas A; Ramalho JS; Novo C; Delannoy P; Videira PA
Biomolecules; 2015 Aug; 5(3):1783-809. PubMed ID: 26270678
[TBL] [Abstract][Full Text] [Related]
37. Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer.
Vasconcelos-Dos-Santos A; Oliveira IA; Lucena MC; Mantuano NR; Whelan SA; Dias WB; Todeschini AR
Front Oncol; 2015; 5():138. PubMed ID: 26161361
[TBL] [Abstract][Full Text] [Related]
38. CDX2 homeoprotein is involved in the regulation of ST6GalNAc-I gene in intestinal metaplasia.
Pinto R; Barros R; Pereira-Castro I; Mesquita P; da Costa LT; Bennett EP; Almeida R; David L
Lab Invest; 2015 Jul; 95(7):718-27. PubMed ID: 25867765
[TBL] [Abstract][Full Text] [Related]
39. Simple sugars to complex disease--mucin-type O-glycans in cancer.
Kudelka MR; Ju T; Heimburg-Molinaro J; Cummings RD
Adv Cancer Res; 2015; 126():53-135. PubMed ID: 25727146
[TBL] [Abstract][Full Text] [Related]
40. RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells.
Tamura F; Sato Y; Hirakawa M; Yoshida M; Ono M; Osuga T; Okagawa Y; Uemura N; Arihara Y; Murase K; Kawano Y; Iyama S; Takada K; Hayashi T; Sato T; Miyanishi K; Kobune M; Takimoto R; Kato J
Gastric Cancer; 2016 Jan; 19(1):85-97. PubMed ID: 25532910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
